Literature DB >> 2850779

Purification of the Sendai virus nonstructural C protein expressed in E. coli, and preparation of antiserum against C protein.

T Omata-Yamada1, K Hagiwara, K Katoh, H Yamada, K Iwasaki.   

Abstract

An expression plasmid, ptac-C, was constructed by inserting the cDNA of the coding region of the Sendai virus nonstructural C protein downstream of the tac promoter of E. coli expression plasmid ptac12-Bam. A new protein produced in E. coli after induction was purified to near homogeneity. The purified protein was found to be identical with the C protein predicted from the C gene cDNA in molecular weight, isoelectric point, amino acid composition, and the amino acid sequence at the N-terminal of the protein as well as those of several fragments obtained on V8 protease digestion. Antiserum raised against the purified protein specifically reacted with the C protein in infected cells. Using this antiserum, the localization of the C protein in infected cells was examined by immunofluorescence, which revealed that it appeared in the cytoplasm but not in nuclei.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850779     DOI: 10.1007/bf01319809

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  The synthesis of sendai virus polypeptides in infected cells.

Authors:  R A Lamb; B W Mahy; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

2.  The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

3.  Nucleotide sequence of the entire protein coding region of canine distemper virus polymerase-associated (P) protein mRNA.

Authors:  T Barrett; S B Shrimpton; S E Russell
Journal:  Virus Res       Date:  1985-11       Impact factor: 3.303

4.  Ribosomal initiation at alternate AUGs on the Sendai virus P/C mRNA.

Authors:  J A Curran; C Richardson; D Kolakofsky
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Messenger RNA encoding the phosphoprotein (P) gene of human parainfluenza virus 3 is bicistronic.

Authors:  D Luk; A Sánchez; A K Banerjee
Journal:  Virology       Date:  1986-09       Impact factor: 3.616

6.  The molecular biology of paramyxoviruses.

Authors:  D W Kingsbury
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy.

Authors:  A Portner; K G Murti; E M Morgan; D W Kingsbury
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

9.  In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses.

Authors:  P R Etkind; R K Cross; R A Lamb; D C Merz; P W Choppin
Journal:  Virology       Date:  1980-01-15       Impact factor: 3.616

10.  Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli.

Authors:  E Amann; J Brosius; M Ptashne
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

View more
  3 in total

1.  Association of the Sendai virus C protein with nucleocapsids.

Authors:  H Yamada; S Hayata; T Omata-Yamada; H Taira; K Mizumoto; K Iwasaki
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Differential sensitivity of two related viruses, Newcastle disease virus and Sendai virus, to interferon in mouse Had-2 cells: selective inhibition of translation of NDV mRNA.

Authors:  K Aoki; M Kawakita
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity.

Authors:  M Itoh; H Hotta; M Homma
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.